» Articles » PMID: 25644891

Detection of Hepatitis C Virus in Patients with Terminal Renal Disease Undergoing Dialysis in Southern Brazil: Prevalence, Risk Factors, Genotypes, and Viral Load Dynamics in Hemodialysis Patients

Overview
Journal Virol J
Publisher Biomed Central
Specialty Microbiology
Date 2015 Feb 4
PMID 25644891
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Hepatitis C (HCV) is a serious public health issue, and it is estimated that 3% of the world's population is infected. Patients in hemodialysis units have an increased risk for contracting HCV, and high prevalence rates have been found in hemodialysis units around the world. This study is aimed at determining the prevalence of HCV in patients with terminal chronic renal disease (tCRD) who have been submitted to hemodialysis and peritoneal dialysis in southern Brazil to characterize the most prevalent genotypes, the viral load, and possible risk factors and to assess the validity between the ELISA and RT-PCR detection methods. Of 320 patients from three dialysis units, 318 participated in this study. According to the medical records, 55 patients were reactive to HCV, as determined via ELISA. All 318 samples were submitted to RT-PCR and genotyped using an Abbott Realtime m2000 system. Data obtained through a questionnaire and chemical variables were associated with the HCV.

Results: The prevalence of HCV was 18.24% (58), and the concordance between the HCV serology and the RT-PCR was 94%. Three patients were diagnosed to be negative for HCV using the ELISA assay but positive when using RT-PCR. Genotype 1 was the most prevalent (46.7%) genotype, within which subtype 1a was the most frequent (74.1%). One of the risk factors associated with HCV infection was the length of time that the patient had been undergoing hemodialysis treatments (p < 0.001). Additionally, the viral load was found to vary when tested before and after hemodialysis (p < 0.001).

Conclusion: The prevalence of HCV in dialysis units continues to remain high, indicating nosocomial contamination. RT-PCR detected the presence of the hepatitis C virus in patients with a non-reactive serology, which highlights the importance of performing molecular tests on dialysis patients. The variation in the viral load in patients submitted to hemodialysis indicates a possible destruction or gripping of viral particles to the dialyzer membrane.

Citing Articles

Prevalence of HCV Infection Among Hemodialysis Patients in Lanzhou of Northwestern China.

Bao K, Chen J, Liu R, Xiang Y, Gao W Infect Drug Resist. 2022; 15:5609-5617.

PMID: 36172622 PMC: 9512538. DOI: 10.2147/IDR.S378600.


Meta-analysis: risk of hepatitis C virus infection associated with hospital-based invasive procedures.

Henriot P, Castry M, Luong Nguyen L, Shimakawa Y, Jean K, Temime L Aliment Pharmacol Ther. 2022; 56(4):558-569.

PMID: 35758763 PMC: 9543323. DOI: 10.1111/apt.17106.


Laboratory Evaluation of Hepatitis C Virus Infection in Patients Undergoing Hemodialysis from North East India.

Kalita D, Deka S, Chamuah K, Ahmed G J Clin Exp Hepatol. 2022; 12(2):475-482.

PMID: 35535106 PMC: 9077174. DOI: 10.1016/j.jceh.2021.05.011.


Persistently high hepatitis C rates in haemodialysis patients in Brazil [a systematic review and meta-analysis].

Niquini R, Da Mota J, Soares Bastos L, da Costa Moreira Barbosa D, Falcao J, Palmieri P Sci Rep. 2022; 12(1):330.

PMID: 35013390 PMC: 8748660. DOI: 10.1038/s41598-021-03961-x.


Circulation of an atypical hepatitis C virus (HCV) strain at a dialysis unit in northeast India.

Kalita D, Deka S, Chamuah K Microbiologyopen. 2020; 10(1):e1147.

PMID: 33369206 PMC: 7884925. DOI: 10.1002/mbo3.1147.


References
1.
Amorim R, Oliveira C, Wyant P, Cerqueira D, Camara G, Flores L . Hepatitis C virus genotypes in blood donors from the Federal District, Central Brazil. Mem Inst Oswaldo Cruz. 2005; 99(8):895-7. DOI: 10.1590/s0074-02762004000800019. View

2.
Carneiro M, Teles S, Dias M, Ferreira R, Naghettine A, Silva S . Decline of hepatitis C infection in hemodialysis patients in Central Brazil: a ten years of surveillance. Mem Inst Oswaldo Cruz. 2005; 100(4):345-9. DOI: 10.1590/s0074-02762005000400002. View

3.
Albuquerque A, Coelho M, Lopes E, Lemos M, Moreira R . Prevalence and risk factors of hepatitis C virus infection in hemodialysis patients from one center in Recife, Brazil. Mem Inst Oswaldo Cruz. 2005; 100(5):467-70. DOI: 10.1590/s0074-02762005000500003. View

4.
Martins R, Teles S, Freitas N, Motta-Castro A, Souto F, Mussi A . Distribution of hepatitis C virus genotypes among blood donors from mid-west region of Brazil. Rev Inst Med Trop Sao Paulo. 2006; 48(1):53-5. DOI: 10.1590/s0036-46652006000100012. View

5.
Fabrizi F, MARTIN P, Dixit V, BREZINA M, Cole M, Vinson S . Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis. 2000; 35(1):122-9. DOI: 10.1016/S0272-6386(00)70310-6. View